Search Results - "Urawa, Naohito"

A 10-year Follow-up Study of a Japanese Family with Ferroportin Disease A: Mild Iron Overload with Mild Hyperferritinemia Co-occurring with Hyperhepcidinemia May Be Benign by Hayashi, Hisao, Yano, Motoyoshi, Urawa, Naohito, Mizutani, Akane, Hamaoka, Shima, Araki, Jun, Kojima, Yuji, Naito, Yutaka, Kato, Ayako, Tatsumi, Yasuaki, Kato, Koichi

“…This is a 10-year follow-up study of a family with ferroportin disease A. The proband, a 59-year-old man showed no noteworthy findings with the exception of an…”
Get full text

Effect of treatment periods on efficacy of glecaprevir and pibrentasvir in chronic hepatitis C: A nationwide, prospective, multicenter study by Morita, Atsuhiro, Tamaki, Nobuharu, Kobashi, Haruhiko, Mori, Nami, Tsuji, Keiji, Takaki, Shintaro, Hasebe, Chitomi, Akahane, Takehiro, Ochi, Hironori, Mashiba, Toshie, Urawa, Naohito, Fujii, Hideki, Mitsuda, Akeri, Kondo, Masahiko, Ogawa, Chikara, Uchida, Yasushi, Narita, Ryoichi, Marusawa, Hiroyuki, Kubotsu, Yoshihito, Matsushita, Tomomichi, Shigeno, Masaya, Yoshida, Hideo, Tanaka, Katsuaki, Okamoto, Eisuke, Kasai, Toyotaka, Ishii, Toru, Okada, Kazuhiko, Kurosaki, Masayuki, Izumi, Namiki

“…Background and aim In patients with chronic hepatitis C, 8 weeks of glecaprevir and pibrentasvir (GLE/PIB) treatment for chronic hepatitis (non‐cirrhosis) and…”
Get full text

Value of the Apparent Diffusion Coefficient for Quantification of Low-Grade Hepatic Encephalopathy by SUGIMOTO, Ryosuke, IWASA, Motoh, MAEDA, Masayuki, URAWA, Naohito, TANAKA, Hideaki, FUJITA, Naoki, KOBAYASHI, Yoshinao, TAKEDA, Kan, KAITO, Masahiko, TAKEI, Yoshiyuki

“…Minimal hepatic encephalopathy (HE) is associated with poorer quality of life and increased work disability. Recently, low-grade cerebral edema has been…”
Get full text

Restriction of dietary calories, fat and iron improves non-alcoholic fatty liver disease by Yamamoto, Mika, Iwasa, Motoh, Iwata, Kazuko, Kaito, Masahiko, Sugimoto, Ryosuke, Urawa, Naohito, Mifuji, Rumi, Konishi, Masayoshi, Kobayashi, Yoshinao, Adachi, Yukihiko

“…Background:  The pathogenesis of non‐alcoholic steatohepatitis (NASH) is unclear. Recent studies suggested that oxidative stress plays an important role in the…”
Get full text

Polymorphism of UDP-glucuronosyltransferase 1A7 gene: A possible new risk factor for lung cancer by Araki, Jun, Kobayashi, Yoshinao, Iwasa, Motoh, Urawa, Naohito, Gabazza, Esteban C., Taguchi, Osamu, Kaito, Masahiko, Adachi, Yukihiko

“…UDP-glucuronosyltransferase (UGT) 1A7 detoxifies hydroxylated benzo-(α)-pyrenes and 2-hydroxyamino-1-methyl-6-phenylimidazo (4,5-β) pyridine. The purpose of…”
Get full text

Influence of phlebotomy on iron-related gene expression levels in the livers of patients with chronic hepatitis C by Fujita, Naoki, Sugimoto, Ryosuke, Urawa, Naohito, Tanaka, Hideaki, Konishi, Masayoshi, Kobayashi, Yoshinao, Iwasa, Motoh, Watanabe, Shozo, Kaito, Masahiko

Get full text

Linkage disequilibrium of UGT1A1 6 and UGT1A1 28 in relation to UGT1A6 and UGT1A7 polymorphisms by Urawa, Naohito, Kobayashi, Yoshinao, Araki, Jun, Sugimoto, Ryosuke, Iwasa, Motoh, Kaito, Masahiko, Adachi, Yukihko

“…UDP-glucuronosyltransferase (UGT) enzymes are responsible for the glucuronidation and detoxification of many endogenous or exogenous xenobiotics. Gilbert's…”
Get full text

Validity of Japanese version of SARC‐F questionnaire in patients with chronic liver disease by Ida, Satoshi, Kojima, Yuji, Hamaoka, Shima, Urawa, Naohito, Araki, Jun, Kaneko, Ryutaro, Murata, Kazuya

“…Background and Aim We aimed to examine the validity of the Japanese version of SARC‐F questionnaire (SARC‐F‐J) that employs the diagnostic criteria for…”
Get full text

Change in Liver Function in Durvalumab Plus Tremelimumab Treatment for Unresectable Hepatocellular Carcinoma by Tamaki, Nobuharu, Mori, Nami, Takaki, Shintaro, Tsuji, Keiji, Tada, Toshifumi, Nakamura, Shinichiro, Ochi, Hironori, Mashiba, Toshie, Doisaki, Masao, Marusawa, Hiroyuki, Kobashi, Haruhiko, Fujii, Hideki, Ogawa, Chikara, Nonogi, Michiko, Arai, Hirotaka, Uchida, Yasushi, Urawa, Naohito, Narita, Ryoichi, Akahane, Takehiro, Kondo, Masahiko, Yasui, Yutaka, Tsuchiya, Kaoru, Izumi, Namiki, Kurosaki, Masayuki

“…Maintaining liver function throughout the treatment of hepatocellular carcinoma (HCC) is crucial, yet the impact of durvalumab plus tremelimumab (DT) treatment…”
Get more information

Viral eradication reduces all-cause mortality in patients with chronic hepatitis C virus infection who had received direct-acting antiviral therapy by Tada, Toshifumi, Kurosaki, Masayuki, Toyoda, Hidenori, Tamaki, Nobuharu, Yasui, Yutaka, Nakamura, Shinichiro, Mori, Nami, Tsuji, Keiji, Ochi, Hironori, Akahane, Takehiro, Kobashi, Haruhiko, Fujii, Hideki, Marusawa, Hiroyuki, Kondo, Masahiko, Urawa, Naohito, Yoshida, Hideo, Uchida, Yasushi, Morita, Atsuhiro, Hasebe, Chitomi, Mitsuda, Akeri, Ogawa, Chikara, Narita, Ryoichi, Kubotsu, Yoshihito, Matsushita, Tomomichi, Shigeno, Masaya, Okamoto, Eisuke, Okada, Kazuhiko, Kasai, Toyotaka, Ishii, Toru, Nonogi, Michiko, Yasuda, Satoshi, Koshiyama, Yuichi, Kumada, Takashi, Izumi, Namiki

“…The impact of hepatitis C virus (HCV) eradication via direct-acting antiviral (DAA) therapy on overall mortality, particularly non-liver-related mortality, is…”
Get full text

Treatment response to durvalumab plus tremelimumab after progression with previous immune checkpoint inhibitor in unresectable hepatocellular carcinoma by Mori, Nami, Tamaki, Nobuharu, Takaki, Shintaro, Tsuji, Keiji, Tada, Toshifumi, Nakamura, Shinichiro, Ochi, Hironori, Mashiba, Toshie, Doisaki, Masao, Marusawa, Hiroyuki, Kobashi, Haruhiko, Fujii, Hideki, Ogawa, Chikara, Nonogi, Michiko, Arai, Hirotaka, Uchida, Yasushi, Urawa, Naohito, Narita, Ryoichi, Akahane, Takehiro, Kondo, Masahiko, Yasui, Yutaka, Tsuchiya, Kaoru, Izumi, Namiki, Kurosaki, Masayuki

“…Although immune checkpoint inhibitors (ICI) are used for unresectable hepatocellular carcinoma (HCC), it is unclear whether sequential ICI treatment-durvalumab…”
Get full text

Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis C by Fujita, Naoki, Sugimoto, Ryosuke, Takeo, Masaki, Urawa, Naohito, Mifuji, Rumi, Tanaka, Hideaki, Kobayashi, Yoshinao, Iwasa, Motoh, Watanabe, Shozo, Adachi, Yukihiko, Kaito, Masahiko

“…Patients with chronic hepatitis C frequently have serum and hepatic iron overload, but the mechanism is unknown. Recently identified hepcidin, exclusively…”
Get full text

Hepatic iron accumulation is associated with disease progression and resistance to interferon/ribavirin combination therapy in chronic hepatitis C by Fujita, Naoki, Sugimoto, Ryosuke, Urawa, Naohito, Araki, Jun, Mifuji, Rumi, Yamamoto, Mika, Horiike, Shinichiro, Tanaka, Hideaki, Iwasa, Motoh, Kobayashi, Yoshinao, Adachi, Yukihiko, Kaito, Masahiko

“…Background and Aims:  Liver iron accumulation in patients with chronic hepatitis C (CHC) has received increasing attention in recent years. The aim of this…”
Get full text

Positron emission tomography image on evaluating intraperitoneal dissemination of malignant gastrointestinal stromal tumor by Kobayashi, Yoshinao, Nakao, Makoto, Konishi, Masayshi, Urawa, Naohito, Iwasa, Motoh, Kaito, Masahiko, Adachi, Yukihiko

“…Herein is a report of a patient with gastrointestinal stromal tumor (GIST) possibly arising from greater omentum accompanying diffuse peritoneal…”
Get more information

Upregulation of transferrin receptor 2 and ferroportin 1 mRNA in the liver of patients with chronic hepatitis C by TAKEO, MASAKI, KOBAYASHI, YOSHINAO, FUJITA, NAOKI, URAWA, NAOHITO, IWASA, MOTOH, HORIIKE, SHINICHIRO, TANAKA, HIDEAKI, KAITO, MASAHIKO, ADACHI, YUKIHIKO

“…Background:  Iron accumulation has been reported to be associated with progression of liver injury. The mechanism of iron accumulation in the liver is not…”
Get full text

Linkage disequilibrium of UGT1A16 and UGT1A128 in relation to UGT1A6 and UGT1A7 polymorphisms by URAWA, Naohito, KOBAYASHI, Yoshinao, ARAKI, Jun, SUGIMOTO, Ryosuke, IWASA, Motoh, KAITO, Masahiko, ADACHI, Yukihko

“…UDP-glucuronosyltransferase (UGT) enzymes are responsible for the glucuronidation and detoxification of many endogenous or exogenous xenobiotics. Gilbert's…”
Get full text

Hepatic arterial infusion of 5-fluorouracil in combination with subcutaneous interferon-alpha for advanced hepatocellular carcinoma by Kuroda, Makoto, Kobayashi, Yoshinao, Urawa, Naohito, Yamamoto, Mika, Mifuji, Rumi, Araki, Jun, Tanaka, Hideaki, Horiike, Shinichiro, Itani, Toshio, Furjita, Naoki, Konishi, Masayoshi, Iwasa, Motoh, Kaito, Masahiko, Adachi, Yukihiko

“…Transcatheter arterial chemoinfusion (TACI) is the main therapeutic modality for advanced hepatocellular carcinoma (HCC) with portal thrombus. However, TACI is…”
Get more information

Role of transferrin receptor 2 in hepatic accumulation of iron in patients with chronic hepatitis C by MIFUJI, RUMI, KOBAYASHI, YOSHINAO, MA, NING, QIANG, QIN LI, URAWA, NAOHITO, HORIIKE, SHINICHIRO, IWASA, MOTOH, KAITO, MASAHIKO, MALAVASI, FABIO, ADACHI, YUKIHIKO

“…Background and Aim:  Iron deposition in the liver is a common finding in patients with chronic hepatitis C (CH‐C). The mechanism of this hepatic accumulation…”
Get full text

HEPATOLOGY: Role of transferrin receptor 2 in hepatic accumulation of iron in patients with chronic hepatitis C by Mifuji, Rumi, Kobayashi, Yoshinao, MA, Ning, Qiang, Qin LI, Urawa, Naohito, Horiike, Shinichiro, Iwasa, Motoh, Kaito, Masahiko, Malavasi, Fabio, Adachi, Yukihiko

“…Background and Aim:Iron deposition in the liver is a common finding in patients with chronic hepatitis C (CH-C). The mechanism of this hepatic accumulation of…”
Get full text

Elevation of 8-isoprostane in patients with hepatitis C virus infection undergoing hemodialysis by Ishihara, Tomoaki, Iwasa, Motoh, Urawa, Naohito, Tanaka, Hideaki, Fujita, Naoki, Kobayashi, Yoshinao, Adachi, Yukihiko, Kaito, Masahiko

Get full text